CNNH | The Center for Neurological and Neurodevelopmental Health

Videos

CNNH – “Bringing it All Together”

Clinical Trials

ADHD Study: SPD489-405

CRCNJ is enrolling children Ages 13-17 diagnosed with ADHD in a research study of an investigational medication. Join a Clinical Trial Symptoms of ADHD include difficulty remembering information, difficulty concentrating, trouble organizing or completing tasks, and procrastination. Qualified participants receive study-related psychological evaluation(s), compensation for time and travel and a 3 month supply of an FDA-approved medication to treat ADHD at no cost on completion of study.

Perampanel,Partial Onset Seizures: E2007-G000-235

CRCNJ is enrolling teens Ages 12-18 in a Perampanel study for partial onset seizures. Join a Clinical Trial This study is for teens that are already on a stable dose of one to three antiepileptic drugs and are continuing to experience breakthrough seizures. The goal of the study is to evaluate the effects of perampanel on cognition and growth. This study lasts about 20 weeks with an extension phase of about 33 weeks.

Pregabalin,Partial Onset Seizures: A0081041

CRCNJ is enrolling children Ages 4-16 in a Pregabalin study for partial onset seizures. Join a Clinical Trial This study is for children who are already on a stable dose of one to three antiepileptic drugs and are continuing to experience breakthrough seizures. The goal of this study is to evaluate if it is effective and well tolerated. The study lasts for about 21 weeks. Children may be eligible to participate in a 1 year extension study at the end of this study.

Perampanel,Seizures: E2007-G000-232

CRCNJ is enrolling children Ages 2-12 in a Perampanel study for all seizure types. Join a Clinical Trial This is an open-label study to evaluate the pharmacokinetics, and to generate preliminary safety, tolerability, and efficacy of perampanel oral suspension when given as an adjunctive therapy in pediatric subjects with epilepsy. This study lasts 1 year with the possibility of further extension.